• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾性骨病的调查与治疗

The investigation and treatment of renal bone disease.

作者信息

Catto G R, MacLeod M

出版信息

Am J Med. 1976 Jul;61(1):64-73.

PMID:937372
Abstract

Neutron activation analysis of a hand has been used to monitor changes in skeletal calcium content of patients undergoing maintenance hemodialysis. Assessed by this technic supplementary magnesium therapy was of value of reducing the progressive losses of skeletal calcium in a proportion of the patients receiving maintenance hemodialysis. Oral calcium supplements produced a decrease in the skeletal calcium losses of all the patients studied. 1-alpha-hydroxycholecalciferol, a potent vitamin D analogue, caused a significant increase in the calcium content of bone in three patients receiving maintenance hemodialysis; it may prove to be a safe and effective form of therapy for azotemic osteodystrophy.

摘要

对手部进行中子活化分析已用于监测维持性血液透析患者骨骼钙含量的变化。通过这种技术评估,补充镁疗法对于减少部分接受维持性血液透析患者骨骼钙的渐进性流失具有价值。口服钙补充剂使所有研究患者的骨骼钙流失减少。1-α-羟胆钙化醇,一种有效的维生素D类似物,使三名接受维持性血液透析的患者骨钙含量显著增加;它可能被证明是治疗氮质血症性骨营养不良的一种安全有效的疗法。

相似文献

1
The investigation and treatment of renal bone disease.肾性骨病的调查与治疗
Am J Med. 1976 Jul;61(1):64-73.
2
The investigation and treatment of renal osteodystrophy.肾性骨营养不良的调查与治疗。
Proc Eur Dial Transplant Assoc. 1975;11:473-80.
3
Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.全身活体中子活化分析在评估1-α-羟胆钙化醇治疗肾性骨营养不良中的应用
Br Med J. 1976 Jul 10;2(6027):79-83. doi: 10.1136/bmj.2.6027.79.
4
[Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
Rev Rhum Mal Osteoartic. 1981 Jul-Sep;48(7-9):535-41.
5
The effect of 1alpha-hydroxyvitamin D3 on calcium and mineral content of bone in renal osteodystrophy.1α-羟维生素D3对肾性骨营养不良患者骨骼钙和矿物质含量的影响。
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:131s-138s. doi: 10.1111/j.1365-2265.1977.tb03373.x.
6
[Experience in the behavior and control of renal osteodystrophy in patients under chronic hemodialysis].[慢性血液透析患者肾性骨营养不良的行为及控制经验]
Gac Med Mex. 1975 Jun;109(6):411-20.
7
Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
Calcif Tissue Res. 1977 May;22 Suppl:94-100. doi: 10.1007/BF02064047.
8
[Clinical picture, diagnosis and therapy of renal osteodystrophy].
Z Urol Nephrol. 1977 Aug;70(8):603-7.
9
[Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].通过三点骨密度测定法评估透析患者的肾性骨营养不良
Przegl Lek. 2000;57(6):334-9.
10
25-hydroxycholecalciferol in the treatment of renal osteodystrophy in haemodialysed patients.25-羟基胆钙化醇治疗血液透析患者的肾性骨营养不良
Int J Artif Organs. 1979 Nov;2(6):278-81.